References analysis of the Wikipedia article "Tymidinkinas" in the Swedish version

doi.org

dx.doi.org

Weissman SM, Smellie RMS, Paul J (December 1960). ”Studies on the biosynthesis of deoxyribonucleic acid by extracts of mammalian cells. IV. The phosphorylation of thymidine”. Biochim. Biophys. Acta 45: sid. 101–10. doi:10.1016/0006-3002(60)91430-X. PMID 13784139.

Boyle DB, Gibbs AJ, Seigman LJ, Both GW, Coupar BE (1987). ”Fowlpox virus thymidine kinase: nucleotide sequence and relationships to other thymidine kinases”. Virology 156 (2): sid. 355–365. doi:10.1016/0042-6822(87)90415-6. PMID 3027984.

Lopez-Otin C, Blasco R, Vinuela E, Munoz M, Simon-Mateo C, Bockamp EO (1990). ”Sequence and evolutionary relationships of African swine fever virus thymidine kinase”. Virology 178 (1): sid. 301–304. doi:10.1016/0042-6822(90)90409-K. PMID 2389555.

Bello LJ (December 1974). ”Regulation of thymidine kinase synthesis in human cells”. Exp. Cell Res. 89 (2): sid. 263–74. doi:10.1016/0014-4827(74)90790-3. PMID 4457349.

Berk AJ, Meyer BJ, Clayton DA (February 1973). ”Mitochondrial-specific thymidine kinase”. Arch. Biochem. Biophys. 154 (2): sid. 563–5. doi:10.1016/0003-9861(73)90009-X. PMID 4632422.

Elsevier SM, Kucherlapati RS, Nichols EA, Creagan RP, Giles RE, Ruddle FH, Willecke K, McDougall JK (October 1974). ”Assignment of the gene for galactokinase to human chromosome 17 and its regional localisation to band q21-22”. Nature 251 (5476): sid. 633–6. doi:10.1038/251633a0. PMID 4371022. Bibcode: 1974Natur.251..633E.

Willecke K, Teber T, Kucherlapati RS, Ruddle FH (May 1977). ”Human mitochondrial thymidine kinase is coded for by a gene on chromosome 16 of the nucleus”. Somatic Cell Genet. 3 (3): sid. 237–45. doi:10.1007/BF01538743. PMID 605384.

Flemington E, Bradshaw HD, Traina-Dorge V, Slagel V, Deininger PL (1987). ”Sequence, structure and promoter characterization of the human thymidine kinase gene”. Gene 52 (2–3): sid. 267–77. doi:10.1016/0378-1119(87)90053-9. PMID 3301530.

Welin M, Kosinska U, Mikkelsen NE, et al. (December 2004). ”Structures of thymidine kinase 1 of human and mycoplasmic origin”. Proc. Natl. Acad. Sci. U.S.A. 101 (52): sid. 17970–5. doi:10.1073/pnas.0406332102. PMID 15611477. Bibcode: 2004PNAS..10117970W.

Munch-Petersen B, Cloos L, Jensen HK, Tyrsted G (1995). ”Human thymidine kinase 1. Regulation in normal and malignant cells”. Adv. Enzyme Regul. 35: sid. 69–89. doi:10.1016/0065-2571(94)00014-T. PMID 7572355. http://linkinghub.elsevier.com/retrieve/pii/006525719400014T.

Li CL, Lu CY, Ke PY, Chang ZF (January 2004). ”Perturbation of ATP-induced tetramerization of human cytosolic thymidine kinase by substitution of serine-13 with aspartic acid at the mitotic phosphorylation site”. Biochem. Biophys. Res. Commun. 313 (3): sid. 587–93. doi:10.1016/j.bbrc.2003.11.147. PMID 14697231. http://linkinghub.elsevier.com/retrieve/pii/S0006291X03025476.

Zhu C, Harlow LS, Berenstein D, Munch-Petersen S, Munch-Petersen B (2006). ”Effect of C-terminal of human cytosolic thymidine kinase (TK1) on in vitro stability and enzymatic properties”. Nucleosides Nucleotides Nucleic Acids 25 (9–11): sid. 1185–8. doi:10.1080/15257770600894436. PMID 17065087.

Mikkelsen NE, Johansson K, Karlsson A, et al. (May 2003). ”Structural basis for feedback inhibition of the deoxyribonucleoside salvage pathway: studies of the Drosophila deoxyribonucleoside kinase”. Biochemistry 42 (19): sid. 5706–12. doi:10.1021/bi0340043. PMID 12741827.

McKnight SL (December 1980). ”The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene”. Nucleic Acids Res. 8 (24): sid. 5949–64. doi:10.1093/nar/8.24.5949. PMID 6258156.

Halliburton IW, Morse LS, Roizman B, Quinn KE (August 1980). ”Mapping of the thymidine kinase genes of type 1 and type 2 herpes simplex viruses using intertypic recombinants”. J. Gen. Virol. 49 (2): sid. 235–53. doi:10.1099/0022-1317-49-2-235. PMID 6255066.

Kit S, Kit M, Qavi H, Trkula D, Otsuka H (November 1983). ”Nucleotide sequence of the herpes simplex virus type 2 (HSV-2) thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide and its comparison with the HSV-1 thymidine kinase gene”. Biochim. Biophys. Acta 741 (2): sid. 158–70. doi:10.1016/0167-4781(83)90056-8. PMID 6317035.

Sawyer MH, Ostrove JM, Felser JM, Straus SE (February 1986). ”Mapping of the varicella zoster virus deoxypyrimidine kinase gene and preliminary identification of its transcript”. Virology 149 (1): sid. 1–9. doi:10.1016/0042-6822(86)90081-4. PMID 3004022.

Kit S, Dubbs DR (April 1963). ”Acquisition of thymidine kinase activity by herpes simplex-infected mouse fibroblast cells”. Biochem. Biophys. Res. Commun. 11: sid. 55–9. doi:10.1016/0006-291X(63)90027-5. PMID 14033128.

Schlosser CA, Steglich C, deWet JR, Scheffler IE (February 1981). ”Cell cycle-dependent regulation of thymidine kinase activity introduced into mouse LMTK- cells by DNA and chromatin-mediated gene transfer”. Proc. Natl. Acad. Sci. U.S.A. 78 (2): sid. 1119–23. doi:10.1073/pnas.78.2.1119. PMID 6940130. Bibcode: 1981PNAS...78.1119S.

Gross MK, Kainz MS, Merrill GF (August 1987). ”The chicken thymidine kinase gene is transcriptionally repressed during terminal differentiation: the associated decline in TK mRNA cannot account fully for the disappearance of TK enzyme activity”. Dev. Biol. 122 (2): sid. 439–51. doi:10.1016/0012-1606(87)90308-3. PMID 3596017.

Sutterluety H, Bartl S, Karlseder J, Wintersberger E, Seiser C (June 1996). ”Carboxy-terminal residues of mouse thymidine kinase are essential for rapid degradation in quiescent cells”. J. Mol. Biol. 259 (3): sid. 383–92. doi:10.1006/jmbi.1996.0327. PMID 8676376.

Chao KS (December 2006). ”Functional imaging for early prediction of response to chemoradiotherapy: 3'-deoxy-3'-18F-fluorothymidine positron emission tomography--a clinical application model of esophageal cancer”. Semin. Oncol. 33 (6 Suppl 11): sid. S59–63. doi:10.1053/j.seminoncol.2006.10.011. PMID 17178290.

Salskov A, Tammisetti VS, Grierson J, Vesselle H (November 2007). ”FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine”. Semin Nucl Med 37 (6): sid. 429–39. doi:10.1053/j.semnuclmed.2007.08.001. PMID 17920350.

de Langen AJ, Klabbers B, Lubberink M, et al. (October 2008). ”Reproducibility of quantitative (18)F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography”. Eur. J. Nucl. Med. Mol. Imaging 36 (3): sid. 389–95. doi:10.1007/s00259-008-0960-5. PMID 18931838.

Shields AF, Lawhorn-Crews JM, Briston DA, et al. (July 2008). ”Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer”. Clin. Cancer Res. 14 (14): sid. 4463–8. doi:10.1158/1078-0432.CCR-07-5243. PMID 18628460.

Köhler G, Milstein C (August 1975). ”Continuous cultures of fused cells secreting antibody of predefined specificity”. Nature 256 (5517): sid. 495–7. doi:10.1038/256495a0. PMID 1172191. Bibcode: 1975Natur.256..495K.

Köhler G, Howe SC, Milstein C (April 1976). ”Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines”. Eur. J. Immunol. 6 (4): sid. 292–5. doi:10.1002/eji.1830060411. PMID 825374.

Köhler G, Milstein C (July 1976). ”Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion”. Eur. J. Immunol. 6 (7): sid. 511–9. doi:10.1002/eji.1830060713. PMID 825377.

Köhler G, Pearson T, Milstein C (May 1977). ”Fusion of T and B cells”. Somatic Cell Genet. 3 (3): sid. 303–12. doi:10.1007/BF01538748. PMID 305123.

Karlström AR, Neumüller M, Gronowitz JS, Källander CF (January 1990). ”Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA”. Mol. Cell. Biochem. 92 (1): sid. 23–35. doi:10.1007/BF00220716. PMID 2155379.

Hagberg H, Glimelius B, Gronowitz JS, Killander A, Källander CFR, Schröder T (July 1984). ”Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: a multivariate analysis”. Scand J Haematol 33 (1): sid. 59–67. doi:10.1111/j.1600-0609.1984.tb02211.x. PMID 6379852.

Gronowitz JS, Hagberg H, Källander CFR, Simonsson B (April 1983). ”The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma”. Br. J. Cancer 47 (4): sid. 487–95. doi:10.1038/bjc.1983.78. PMID 6849793.

Hallek M, Wanders L, Strohmeyer S, Emmerich B (July 1992). ”Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications”. Ann. Hematol. 65 (1): sid. 1–5. doi:10.1007/BF01715117. PMID 1643153.

Rehn S, Gronowitz JS, Källander C, Sundström C, Glimelius B (May 1995). ”Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas”. Br. J. Cancer 71 (5): sid. 1099–105. doi:10.1038/bjc.1995.213. PMID 7734308.

Suki S, Swan F, Tucker S, et al. (June 1995). ”Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase”. Leuk. Lymphoma 18 (1–2): sid. 87–92. doi:10.3109/10428199509064927. PMID 8580834.

Hallek M, Wanders L, Ostwald M, et al. (August 1996). ”Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma”. Leuk. Lymphoma 22 (5–6): sid. 439–47. doi:10.3109/10428199609054782. PMID 8882957.

von Euler H, Einarsson R, Olsson U, Lagerstedt AS, Eriksson S (2004). ”Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease”. J. Vet. Intern. Med. 18 (5): sid. 696–702. doi:10.1892/0891-6640(2004)18<696:STKAID>2.0.CO;2. ISSN 0891-6640. PMID 15515587.

Voneuler, H.; Ohrvik, A.; Eriksson, S. (2006). ”A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs”. Research in Veterinary Science 80 (1): sid. 17–24. doi:10.1016/j.rvsc.2005.05.001. PMID 16140350.

Källander CFR, Simonsson B, Gronowitz JS, Nilsson K (April 1987). ”Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia”. Eur. J. Haematol. 38 (4): sid. 331–7. doi:10.1111/j.1600-0609.1987.tb00007.x. PMID 3609253.

Simonsson B, Källander CFR, Brenning G, Killander A, Gronowitz JS, Bergström R (May 1988). ”Biochemical markers in multiple myeloma: a multivariate analysis”. Br. J. Haematol. 69 (1): sid. 47–53. doi:10.1111/j.1365-2141.1988.tb07601.x. PMID 3289607.

Simonsson B, Källander CFR, Brenning G, Killander A, Ahre A, Gronowitz JS (October 1985). ”Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma”. Br. J. Haematol. 61 (2): sid. 215–24. doi:10.1111/j.1365-2141.1985.tb02820.x. PMID 4041368.

Musto P, Bodenizza C, Falcone A, et al. (May 1995). ”Prognostic relevance of serum thymidine kinase in primary myelodysplastic syndromes: relationship to development of acute myeloid leukaemia”. Br. J. Haematol. 90 (1): sid. 125–30. doi:10.1111/j.1365-2141.1995.tb03390.x. PMID 7786774.

Aul C, Germing U, Gattermann N, Söhngen D, Heyll A (September 1996). ”[The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome]” (på german). Dtsch. Med. Wochenschr. 121 (37): sid. 1113–8. doi:10.1055/s-2008-1043114. PMID 8925725.

Letocha H, Eklöv S, Gronowitz S, Norlén BJ, Nilsson S (July 1996). ”Deoxythymidine kinase in the staging of prostatic adenocarcinoma”. Prostate 29 (1): sid. 15–9. doi:10.1002/(SICI)1097-0045(199607)29:1<15::AID-PROS2>3.0.CO;2-H. PMID 8685050.

Lewenhaupt A, Ekman P, Eneroth P, Nilsson B (August 1990). ”Tumour markers as prognostic aids in prostatic carcinoma”. Br J Urol 66 (2): sid. 182–7. doi:10.1111/j.1464-410X.1990.tb14900.x. PMID 1697204.

Ekman P, Lewenhaupt A (1991). ”Serum tumour markers in human prostatic carcinoma. The value of a marker panel for prognostic information”. Acta Oncol 30 (2): sid. 173–5. doi:10.3109/02841869109092345. PMID 2029401.

Nisman B, Allweis T, Kaduri L, et al. (2010). ”Serum thymidine kinase 1 activity in breast cancer”. Cancer Biomark 7 (2): sid. 65–72. doi:10.3233/CBM-2010-0148. PMID 21178264.

Nisman B, Yutkin V, Nechushtan H, et al. (August 2010). ”Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy”. Urology 76 (2): sid. 513.e1–6. doi:10.1016/j.urology.2010.04.034. PMID 20573390.

Lin TS, Neenan JP, Cheng YC, Prusoff WH (April 1976). ”Synthesis and antiviral activity of 5- and 5'-substituted thymidine analogs”. Journal of Medicinal Chemistry 19 (4): sid. 495–8. doi:10.1021/jm00226a009. PMID 177781.

Shannon WM, Schabel FM (1980). ”Antiviral agents as adjuncts in cancer chemotherapy”. Pharmacol. Ther. 11 (2): sid. 263–390. doi:10.1016/0163-7258(80)90034-0. PMID 7001501. http://linkinghub.elsevier.com/retrieve/pii/0163-7258(80)90034-0.

Hirsch MS (May 1990). ”Chemotherapy of human immunodeficiency virus infections: current practice and future prospects”. J. Infect. Dis. 161 (5): sid. 845–57. doi:10.1093/infdis/161.5.845. PMID 1691243.

Shiau GT, Schinazi RF, Chen MS, Prusoff WH (February 1980). ”Synthesis and biological activities of 5-(hydroxymethyl, azidomethyl, or aminomethyl)-2'-deoxyuridine and related 5'-substituted analogues”. Journal of Medicinal Chemistry 23 (2): sid. 127–33. doi:10.1021/jm00176a005. PMID 6244411.

Mitsuya H, Weinhold KJ, Furman PA, et al. (October 1985). ”3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro”. Proc. Natl. Acad. Sci. U.S.A. 82 (20): sid. 7096–100. doi:10.1073/pnas.82.20.7096. PMID 2413459. PMC: 391317. Bibcode: 1985PNAS...82.7096M. http://www.pnas.org/cgi/pmidlookup?view=long&pmid=2413459.

Baba M, Pauwels R, Herdewijn P, De Clercq E, Desmyter J, Vandeputte M (January 1987). ”Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro”. Biochem. Biophys. Res. Commun. 142 (1): sid. 128–34. doi:10.1016/0006-291X(87)90460-8. PMID 3028398. http://linkinghub.elsevier.com/retrieve/pii/0006-291X(87)90460-8.

Ohrvik A, Lindh M, Einarsson R, Grassi J, Eriksson S (September 2004). ”Sensitive nonradiometric method for determining thymidine kinase 1 activity”. Clin. Chem. 50 (9): sid. 1597–606. doi:10.1373/clinchem.2003.030379. PMID 15247154.

Prusoff WH (March 1959). ”Synthesis and biological activities of iododeoxyuridine, an analog of thymidine”. Biochim. Biophys. Acta 32 (1): sid. 295–6. doi:10.1016/0006-3002(59)90597-9. PMID 13628760.

Morgenroth A, Deisenhofer S, Glatting G, et al. (November 2008). ”Preferential Tumor Targeting and Selective Tumor Cell Cytotoxicity of 5-[131/125I]Iodo-4'-Thio-2'-Deoxyuridine”. Clin. Cancer Res. 14 (22): sid. 7311–9. doi:10.1158/1078-0432.CCR-08-0907. PMID 19010846.

Black ME, Hruby DE (June 1990). ”Quaternary structure of vaccinia virus thymidine kinase”. Biochem. Biophys. Res. Commun. 169 (3): sid. 1080–6. doi:10.1016/0006-291X(90)92005-K. PMID 2114104. http://www.biomedcentral.com/1472-6807/6/22.

Preuss, Ellen; Muik, Alexander; Weber, Kristoffer; Otte, Jürgen; von Laer, Dorothee; Fehse, Boris (2011-11). ”Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect”. Journal of Molecular Medicine (Berlin, Germany) 89 (11): sid. 1113–1124. doi:10.1007/s00109-011-0777-8. ISSN 1432-1440. PMID 21698427. https://www.ncbi.nlm.nih.gov/pubmed/21698427.

Kanai F, Shiratori Y, Yoshida Y, et al. (June 1996). ”Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene”. Hepatology 23 (6): sid. 1359–68. doi:10.1002/hep.510230611. PMID 8675152.

Byun Y, Thirumamagal BT, Yang W, Eriksson S, Barth RF, Tjarks W (September 2006). ”Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors”. Journal of Medicinal Chemistry 49 (18): sid. 5513–23. doi:10.1021/jm060413w. PMID 16942024.

Thirumamagal BT, Johnsamuel J, Cosquer GY, et al. (2006). ”Boronated thymidine analogues for boron neutron capture therapy”. Nucleosides Nucleotides Nucleic Acids 25 (8): sid. 861–6. doi:10.1080/15257770600793844. PMID 16901817.

Narayanasamy S, Thirumamagal BT, Johnsamuel J, et al. (October 2006). ”Hydrophilically enhanced 3-carboranyl thymidine analogues (3CTAs) for boron neutron capture therapy (BNCT) of cancer”. Bioorg. Med. Chem. 14 (20): sid. 6886–99. doi:10.1016/j.bmc.2006.06.039. PMID 16831554.

Byun Y, Narayanasamy S, Johnsamuel J, et al. (March 2006). ”3-Carboranyl thymidine analogues (3CTAs) and other boronated nucleosides for boron neutron capture therapy”. Anticancer Agents Med Chem 6 (2): sid. 127–44. doi:10.2174/187152006776119171. PMID 16529536. http://www.eurekaselect.com/55733/article.

Byun Y, Yan J, Al-Madhoun AS, et al. (February 2005). ”Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy”. Journal of Medicinal Chemistry 48 (4): sid. 1188–98. doi:10.1021/jm0491896. PMID 15715485.

Barth RF, Yang W, Al-Madhoun AS, et al. (September 2004). ”Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors”. Cancer Res. 64 (17): sid. 6287–95. doi:10.1158/0008-5472.CAN-04-0437. PMID 15342417.

Al-Madhoun AS, Johnsamuel J, Barth RF, Tjarks W, Eriksson S (September 2004). ”Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy”. Cancer Res. 64 (17): sid. 6280–6. doi:10.1158/0008-5472.CAN-04-0197. PMID 15342416.

Johnsamuel J, Lakhi N, Al-Madhoun AS, et al. (September 2004). ”Synthesis of ethyleneoxide modified 3-carboranyl thymidine analogues and evaluation of their biochemical, physicochemical, and structural properties”. Bioorg. Med. Chem. 12 (18): sid. 4769–81. doi:10.1016/j.bmc.2004.07.032. PMID 15336255.

Byun Y, Yan J, Al-Madhoun AS, et al. (November 2004). ”The synthesis and biochemical evaluation of thymidine analogues substituted with nido carborane at the N-3 position”. Appl Radiat Isot 61 (5): sid. 1125–30. doi:10.1016/j.apradiso.2004.05.023. PMID 15308203.

Yan J, Naeslund C, Al-Madhoun AS, et al. (August 2002). ”Synthesis and biological evaluation of 3'-carboranyl thymidine analogues”. Bioorg. Med. Chem. Lett. 12 (16): sid. 2209–12. doi:10.1016/S0960-894X(02)00357-8. PMID 12127539. http://linkinghub.elsevier.com/retrieve/pii/S0960894X02003578.

Barth RF, Yang W, Wu G, et al. (November 2008). ”Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors”. Proc. Natl. Acad. Sci. U.S.A. 105 (45): sid. 17493–7. doi:10.1073/pnas.0809569105. PMID 18981415. Bibcode: 2008PNAS..10517493B.

Gronowitz JS, Källander FR, Diderholm H, Hagberg H, Pettersson U (January 1984). ”Application of an in vitro assay for serum thymidine kinase: results on viral disease and malignancies in humans”. Int. J. Cancer 33 (1): sid. 5–12. doi:10.1002/ijc.2910330103. PMID 6693195.

Kimmel N, Friedman MG, Sarov I (May 1982). ”Enzyme-linked immunosorbent assay (ELISA) for detection of herpes simplex virus-specific IgM antibodies”. J. Virol. Methods 4 (4–5): sid. 219–27. doi:10.1016/0166-0934(82)90068-4. PMID 6286702. http://linkinghub.elsevier.com/retrieve/pii/0166-0934(82)90068-4.

Romain S, Spyratos F, Guirou O, Deytieux S, Chinot O, Martin PM (1994). ”Technical evaluation of thymidine kinase assay in cytosols from breast cancers. EORTC Receptor Study Group Report”. Eur. J. Cancer 30A (14): sid. 2163–5. doi:10.1016/0959-8049(94)00376-G. PMID 7857717.

Arnér ES, Spasokoukotskaja T, Eriksson S (October 1992). ”Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues”. Biochem. Biophys. Res. Commun. 188 (2): sid. 712–8. doi:10.1016/0006-291X(92)91114-6. PMID 1359886. http://linkinghub.elsevier.com/retrieve/pii/0006-291X(92)91114-6.

Wang L, Eriksson S (June 2008). ”5-Bromovinyl 2'-deoxyuridine phosphorylation by mitochondrial and cytosolic thymidine kinase (TK2 and TK1) and its use in selective measurement of TK2 activity in crude extracts”. Nucleosides Nucleotides Nucleic Acids 27 (6): sid. 858–62. doi:10.1080/15257770802146510. PMID 18600552.

Schollenberger S, Taureck D, Wilmanns W (November 1972). ”[Enzymes of thymidine and thymidylate metabolism in normal and pathological blood and bone marrow cells]” (på german). Blut 25 (5): sid. 318–34. doi:10.1007/BF01631814. PMID 4508724.

Nakao K, Fujioka S (April 1968). ”Thymidine kinase activity in the human bone marrow from various blood diseases”. Life Sci. 7 (8): sid. 395–9. doi:10.1016/0024-3205(68)90039-8. PMID 5649653.

Wickramasinghe SN, Olsen I, Saunders JE (September 1975). ”Thymidine kinase activity in human bone marrow cells”. Scand J Haematol 15 (2): sid. 139–44. doi:10.1111/j.1600-0609.1975.tb01065.x. PMID 1059244.

Persson L, Gronowitz SJ, Källander CF (1986). ”Thymidine kinase in extracts of human brain tumours”. Acta Neurochir (Wien) 80 (3–4): sid. 123–7. doi:10.1007/BF01812286. PMID 3012969.

Lipkin M (July 1971). ”Proliferation and differentiation of normal and neoplastic cells in the colon of man”. Cancer 28 (1): sid. 38–40. doi:10.1002/1097-0142(197107)28:1<38::AID-CNCR2820280108>3.0.CO;2-W. PMID 5110642.

Lipkin M, Deschner E, Troncale F (1970). ”Cell differentiation and the development of colonic neoplasms”. CA Cancer J Clin 20 (6): sid. 386–90. doi:10.3322/canjclin.20.6.386. PMID 4992499. http://onlinelibrary.wiley.com/doi/10.3322/canjclin.20.6.386/pdf.

Weber G, Lui MS, Takeda E, Denton JE (September 1980). ”Enzymology of human colon tumors”. Life Sci. 27 (9): sid. 793–9. doi:10.1016/0024-3205(80)90333-1. PMID 7412505.

Sakamoto S, Sagara T, Iwama T, Kawasaki T, Okamoto R (June 1985). ”Increased activities of thymidine kinase isozymes in human colon polyp and carcinoma”. Carcinogenesis 6 (6): sid. 917–9. doi:10.1093/carcin/6.6.917. PMID 4006080. http://carcin.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=4006080.

Sakamoto S, Okamoto R (October 1992). ”Thymidine kinase activity in familial adenomatous polyposis”. Tohoku J. Exp. Med. 168 (2): sid. 291–301. doi:10.1620/tjem.168.291. PMID 1339104. Arkiverad från originalet den 19 december 2012. https://archive.is/20121219081105/https://www.jstage.jst.go.jp/article/tjem1920/168/2/168_2_291/_article.

O'Neill KL, Hoper M, Odling-Smee GW (December 1992). ”Can thymidine kinase levels in breast tumors predict disease recurrence?”. J. Natl. Cancer Inst. 84 (23): sid. 1825–8. doi:10.1093/jnci/84.23.1825. PMID 1433372. http://jnci.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=1433372.

Romain S, Chinot O, Guirou O, Soullière M, Martin PM (October 1994). ”Biological heterogeneity of ER-positive breast cancers in the post-menopausal population”. Int. J. Cancer 59 (1): sid. 17–9. doi:10.1002/ijc.2910590105. PMID 7927897.

Sakamoto S, Iwama T, Ebuchi M, et al. (April 1986). ”Increased activities of thymidine kinase isozymes in human mammary tumours”. Br J Surg 73 (4): sid. 272–3. doi:10.1002/bjs.1800730409. PMID 3697655.

Greengard O, Head JF, Goldberg SL, Kirschner PA (February 1982). ”Enzyme pathology and the histologic categorization of human lung tumors: the continuum of quantitative biochemical indices of neoplasticity”. Cancer 49 (3): sid. 460–7. doi:10.1002/1097-0142(19820201)49:3<460::AID-CNCR2820490312>3.0.CO;2-Y. PMID 6277448.

Greengard O, Head JF, Goldberg SL, Kirschner PA (April 1985). ”Biochemical measure of the volume doubling time of human pulmonary neoplasms”. Cancer 55 (7): sid. 1530–5. doi:10.1002/1097-0142(19850401)55:7<1530::AID-CNCR2820550720>3.0.CO;2-V. PMID 2983858.

Konishi T, Miyama T, Sakamoto S, et al. (June 1992). ”Activities of thymidylate synthetase and thymidine kinase in gastric cancer”. Surg Oncol 1 (3): sid. 215–21. doi:10.1016/0960-7404(92)90067-U. PMID 1341254. http://linkinghub.elsevier.com/retrieve/pii/0960-7404(92)90067-U.

Borovanský J, Stríbrná J, Elleder M, Netíková I (October 1994). ”Thymidine kinase in malignant melanoma”. Melanoma Res. 4 (5): sid. 275–9. doi:10.1097/00008390-199410000-00001. PMID 7858409.

Sakamoto S, Murakami S, Sugawara M, Mishima Y, Okamoto R (1991). ”Increased activities of thymidylate synthetase and thymidine kinase in human thyroid tumors”. Thyroid 1 (4): sid. 347–51. doi:10.1089/thy.1991.1.347. PMID 1841732.

Wilms K, Wilmanns W (September 1972). ”[Effects of dauno-rubidomycin and adriamycin on enzymes of DNA synthesis in leukocytes in vivo and in culture]” (på german). Klin. Wochenschr. 50 (18): sid. 866–70. doi:10.1007/BF01488943. PMID 4507472.

Zhang HJ, Kennedy BJ, Kiang DT (1984). ”Thymidine kinase as a predictor of response to chemotherapy in advanced breast cancer”. Breast Cancer Res. Treat. 4 (3): sid. 221–5. doi:10.1007/BF01806488. PMID 6487823.

nih.gov

ncbi.nlm.nih.gov

Kit S (December 1985). ”Thymidine kinase”. Microbiol. Sci. 2 (12): sid. 369–75. PMID 3939993.

Wintersberger E (February 1997). ”Regulation and biological function of thymidine kinase”. Biochem. Soc. Trans. 25 (1): sid. 303–8. PMID 9056888.

Reichard P, Estborn B (February 1951). ”Utilization of desoxyribosides in the synthesis of polynucleotides”. J. Biol. Chem. 188 (2): sid. 839–46. PMID 14824173. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=14824173.

Bollum FJ, Van Potter R (August 1958). ”Incorporation of thymidine into deoxyribonucleic acid by enzymes from rat tissues”. J. Biol. Chem. 233 (2): sid. 478–82. PMID 13563524. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=13563524.

Littlefield JW (February 1966). ”The periodic synthesis of thymidine kinase in mouse fibroblasts”. Biochim. Biophys. Acta 114 (2): sid. 398–403. PMID 4223355.

Bello LJ (December 1974). ”Regulation of thymidine kinase synthesis in human cells”. Exp. Cell Res. 89 (2): sid. 263–74. doi:10.1016/0014-4827(74)90790-3. PMID 4457349.

Berk AJ, Clayton DA (April 1973). ”A genetically distinct thymidine kinase in mammalian mitochondria. Exclusive labeling of mitochondrial deoxyribonucleic acid”. J. Biol. Chem. 248 (8): sid. 2722–9. PMID 4735344. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=4735344.

Berk AJ, Meyer BJ, Clayton DA (February 1973). ”Mitochondrial-specific thymidine kinase”. Arch. Biochem. Biophys. 154 (2): sid. 563–5. doi:10.1016/0003-9861(73)90009-X. PMID 4632422.

VAN POTTER (1963). ”Feedback Inhibition of Thymidine Kinase by Thymidine Triphosphate”. Exp. Cell Res. 24: sid. SUPPL9:259–62. PMID 14046233.

Severin ES, Itkes AV, Kartasheva ON, Tunitskaya VL, Turpaev KT, Kafiani CA (1985). ”Regulation of 2-5 A phosphodiesterase activity by cAMP-dependent phosphorylation: mechanism and biological role”. Adv. Enzyme Regul. 23: sid. 365–76. PMID 3000146.

Fischer PH, Phillips AW (May 1984). ”Antagonism of feedback inhibition. Stimulation of the phosphorylation of thymidine and 5-iodo-2'-deoxyuridine by 5-iodo-5'-amino-2',5'-dideoxyuridine”. Mol. Pharmacol. 25 (3): sid. 446–51. PMID 6727866.

Fischer PH, Vazquez-Padua MA, Reznikoff CA (1986). ”Perturbation of thymidine kinase regulation: a novel chemotherapeutic approach”. Adv. Enzyme Regul. 25: sid. 21–34. PMID 3812083.

Fischer PH, Vazquez-Padua MA, Reznikoff CA, Ratschan WJ (September 1986). ”Preferential stimulation of iododeoxyuridine phosphorylation by 5'-aminothymidine in human bladder cancer cells in vitro”. Cancer Res. 46 (9): sid. 4522–6. PMID 3731105.

Fischer PH, Fang TT, Lin TS, Hampton A, Bruggink J (April 1988). ”Structure-activity analysis of antagonism of the feedback inhibition of thymidine kinase”. Biochem. Pharmacol. 37 (7): sid. 1293–8. PMID 3355601.

Vazquez-Padua MA, Kunugi K, Fischer PH (January 1989). ”Enzyme regulatory site-directed drugs: study of the interactions of 5'-amino-2', 5'-dideoxythymidine (5'-AdThd) and thymidine triphosphate with thymidine kinase and the relationship to the stimulation of thymidine uptake by 5'-AdThd in 647V cells”. Mol. Pharmacol. 35 (1): sid. 98–104. PMID 2536472.

Vazquez-Padua MA, Fischer PH, Christian BJ, Reznikoff CA (May 1989). ”Basis for the differential modulation of the uptake of 5-iododeoxyuridine by 5'-aminothymidine among various cell types”. Cancer Res. 49 (9): sid. 2415–21. PMID 2706629.

Vázquez-Padua MA (March 1994). ”Modulation of thymidine kinase activity: a biochemical strategy to enhance the activation of antineoplastic drugs”. P R Health Sci J 13 (1): sid. 19–23. PMID 8016290.

McDougall JK, Masse TH, Galloway DA (March 1980). ”Location and cloning of the herpes simplex virus type 2 thymidine kinase gene”. J. Virol. 33 (3): sid. 1221–4. PMID 6245273. PMC: 288658. http://jvi.asm.org/cgi/content/abstract/33/3/1221.

Littler E, Zeuthen J, McBride AA, Trøst Sørensen E, Powell KL, Walsh-Arrand JE, Arrand JR (August 1986). ”Identification of an Epstein-Barr virus-coded thymidine kinase”. EMBO J. 5 (8): sid. 1959–66. PMID 3019675.

Coppock DL, Pardee AB (August 1987). ”Control of thymidine kinase mRNA during the cell cycle”. Mol. Cell. Biol. 7 (8): sid. 2925–32. PMID 3670299. PMC: 367911. http://mcb.asm.org/cgi/content/abstract/7/8/2925. ”Arkiverade kopian”. Arkiverad från originalet den 27 september 2011. https://web.archive.org/web/20110927124557/http://mcb.asm.org/cgi/content/abstract/7/8/2925. Läst 10 mars 2014.

Stewart CJ, Ito M, Conrad SE (March 1987). ”Evidence for transcriptional and post-transcriptional control of the cellular thymidine kinase gene”. Mol. Cell. Biol. 7 (3): sid. 1156–63. PMID 3561412. PMC: 365188. http://mcb.asm.org/cgi/content/abstract/7/3/1156. ”Arkiverade kopian”. Arkiverad från originalet den 27 september 2011. https://web.archive.org/web/20110927124616/http://mcb.asm.org/cgi/content/abstract/7/3/1156. Läst 10 mars 2014.

Piper AA, Tattersall MH, Fox RM (December 1980). ”The activities of thymidine metabolising enzymes during the cell cycle of a human lymphocyte cell line LAZ-007 synchronised by centrifugal elutriation”. Biochim. Biophys. Acta 633 (3): sid. 400–9. PMID 6260157.

Pelka-Fleischer R, Ruppelt W, Wilmanns W, Sauer H, Schalhorn A (March 1987). ”Relation between cell cycle stage and the activity of DNA-synthesizing enzymes in cultured human lymphoblasts: investigations on cell fractions enriched according to cell cycle stages by way of centrifugal elutriation”. Leukemia 1 (3): sid. 182–7. PMID 3669741.

Sherley JL, Kelly TJ (June 1988). ”Regulation of human thymidine kinase during the cell cycle”. J. Biol. Chem. 263 (17): sid. 8350–8. PMID 3372530. http://www.jbc.org/cgi/content/abstract/263/17/8350. Arkiverad 26 januari 2005 hämtat från the Wayback Machine. ”Arkiverade kopian”. Arkiverad från originalet den 26 januari 2005. https://web.archive.org/web/20050126074605/http://www.jbc.org/cgi/content/abstract/263/17/8350. Läst 10 mars 2014.

Kauffman MG, Kelly TJ (May 1991). ”Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis”. Mol. Cell. Biol. 11 (5): sid. 2538–46. PMID 1708095. PMC: 360023. http://mcb.asm.org/cgi/content/abstract/11/5/2538. ”Arkiverade kopian”. Arkiverad från originalet den 27 september 2011. https://web.archive.org/web/20110927124755/http://mcb.asm.org/cgi/content/abstract/11/5/2538. Läst 10 mars 2014.

Johnson HA, Rubini JR, Cronkite EP, Bond VP (1960). ”Labeling of human tumor cells in vivo by tritiated thymidine”. Lab. Invest. 9: sid. 460–5. PMID 14407455.

Barthel H, Cleij MC, Collingridge DR, et al. (July 2003). ”3'-deoxy-3'-[18Ffluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography”]. Cancer Res. 63 (13): sid. 3791–8. PMID 12839975. http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=12839975.

Köhler G, Pearson T, Milstein C (May 1977). ”Fusion of T and B cells”. Somatic Cell Genet. 3 (3): sid. 303–12. doi:10.1007/BF01538748. PMID 305123.

Milstein C, Adetugbo K, Cowan NJ, Kohler G, Secher DS (May 1978). ”Expression of antibody genes in tissue culture: structural mutants and hybrid cells”. Natl Cancer Inst Monogr (48): sid. 321–30. PMID 107455.

Doi S, Naito K, Yamada K (March 1990). ”Serum deoxythymidine kinase as a progressive marker of hematological malignancy”. Nagoya J Med Sci 52 (1–4): sid. 19–26. PMID 2381458.

Ellims PH, Van der Weyden MB, Medley G (February 1981). ”Thymidine kinase isoenzymes in human malignant lymphoma”. Cancer Res. 41 (2): sid. 691–5. PMID 7448815. http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=7448815.

Bogni A, Cortinois A, Grasselli G, et al. (1994). ”Thymidine kinase (TK) activity as a prognostic parameter of survival in lymphoma patients”. J. Biol. Regul. Homeost. Agents 8 (4): sid. 121–5. PMID 7660854.

Rivkina, A.; Vitols, G.; Murovska, M.; Lejniece, S. (2011-6). ”Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels”. Experimental Oncology 33 (2): sid. 99–103. ISSN 1812-9269. PMID 21716207. https://www.ncbi.nlm.nih.gov/pubmed/21716207.

Rivkina, A.; Vitols, G.; Murovska, M.; Lejniece, S. (2011). ”Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels”. Experimental oncology 33 (2): sid. 99–103. PMID 21716207. edit

Larson A, Fritjofsson A, Norlén BJ, Gronowitz JS, Ronquist G (1985). ”Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma”. Scand. J. Clin. Lab. Invest. Suppl. 179: sid. 81–8. PMID 2417306.

Nisman B, Allweis T, Kaduri L, et al. (2010). ”Serum thymidine kinase 1 activity in breast cancer”. Cancer Biomark 7 (2): sid. 65–72. doi:10.3233/CBM-2010-0148. PMID 21178264.

Ellims PH, Hayman RJ, Van der Weyden MB (July 1979). ”Expression of fetal thymidine kinase in human cobalamin or folate deficient lymphocytes”. Biochem. Biophys. Res. Commun. 89 (1): sid. 103–7. PMID 475797.

Neumuller M, Källander CF, Gronowitz JS (1989). ”Detection and characteristics of DNA polymerase activity in serum from patients with malignant, viral, or B12-deficiency disease”. Enzyme 41 (1): sid. 6–16. PMID 2543552.

Tufveson G, Tötterman TH, Källander CF, Hagström A, Gronowitz JS (June 1988). ”Serum thymidine-kinase and cytomegalovirus-specific antibodies after renal transplantation”. Transplant. Proc. 20 (3): sid. 405–7. PMID 2837850.

Källander CF, Gronowitz JS, Olding-Stenkvist E (February 1983). ”Rapid diagnosis of varicella-zoster virus infection by detection of viral deoxythymidine kinase in serum and vesicle fluid”. J. Clin. Microbiol. 17 (2): sid. 280–7. PMID 6339548.

Helgstrand E, Oberg B (1980). ”Enzymatic targets in virus chemotherapy”. Antibiot Chemother 27: sid. 22–69. PMID 6996606.

Hamamoto Y, Nakashima H, Matsui T, Matsuda A, Ueda T, Yamamoto N (June 1987). ”Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus”. Antimicrob. Agents Chemother. 31 (6): sid. 907–10. PMID 3039911. PMC: 284209. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=3039911.

Johnson VA, Hirsch MS (1990). ”New developments in antiretroviral drug therapy for human immunodeficiency virus infections. Ganciclover is a 5' monophosphate that does not require thymidine kinase activation and thus expresses higher toxicity to host enzymes due to a decrease in selectivity”. AIDS Clin Rev: sid. 235–72. PMID 1707295.

Mar EC, Chiou JF, Cheng YC, Huang ES (March 1985). ”Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine”. J. Virol. 53 (3): sid. 776–80. PMID 2983088. PMC: 254706. http://jvi.asm.org/cgi/pmidlookup?view=long&pmid=2983088.

Nicholas TW, Read SB, Burrows FJ, Kruse CA (April 2003). ”Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects”. Histol. Histopathol. 18 (2): sid. 495–507. PMID 12647801. http://www.hh.um.es/Abstracts/Vol_18/18_2/18_2_495.htm.

Hart IR (February 1996). ”Tissue specific promoters in targeting systemically delivered gene therapy”. Semin. Oncol. 23 (1): sid. 154–8. PMID 8607025.

Wills KN, Huang WM, Harris MP, Machemer T, Maneval DC, Gregory RJ (September 1995). ”Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene”. Cancer Gene Ther. 2 (3): sid. 191–7. PMID 8528962.

Ido A, Nakata K, Kato Y, et al. (July 1995). ”Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter”. Cancer Res. 55 (14): sid. 3105–9. PMID 7541712. http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=7541712.

Garver RI, Goldsmith KT, Rodu B, Hu PC, Sorscher EJ, Curiel DT (January 1994). ”Strategy for achieving selective killing of carcinomas”. Gene Ther. 1 (1): sid. 46–50. PMID 7584059.

Hart IR (1996). ”Transcriptionally targeted gene therapy”. Curr. Top. Microbiol. Immunol. 213 (3): sid. 19–25. PMID 8815006.

Gronowitz JS, Källander CF (August 1980). ”Optimized assay for thymidine kinase and its application to the detection of antibodies against herpes simplex virus type 1- and 2-induced thymidine kinase”. Infect. Immun. 29 (2): sid. 425–34. PMID 6260651. PMC: 551136. http://iai.asm.org/cgi/pmidlookup?view=long&pmid=6260651.

Gronowitz JS, Källander CF (1983). ”A sensitive assay for detection of deoxythymidine kinase and its application to herpesvirus diagnosis”. Curr. Top. Microbiol. Immunol. 104: sid. 235–45. PMID 6307593.

He Q, Zou L, Zhang PA, Lui JX, Skog S, Fornander T (2000). ”The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody”. Int. J. Biol. Markers 15 (2): sid. 139–46. PMID 10883887.

Huang S, Lin J, Guo N, et al. (2011). ”Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression”. Asian Pac. J. Cancer Prev. 12 (2): sid. 497–505. PMID 21545220.

Nakao K, Fujioka S (April 1968). ”Thymidine kinase activity in the human bone marrow from various blood diseases”. Life Sci. 7 (8): sid. 395–9. doi:10.1016/0024-3205(68)90039-8. PMID 5649653.

Herzfeld A, Greengard O (November 1980). ”Enzyme activities in human fetal and neoplastic tissues”. Cancer 46 (9): sid. 2047–54. PMID 6253048.

Gordon HL, Bardos TJ, Chmielewicz ZF, Ambrus JL (October 1968). ”Comparative study of the thymidine kinase and thymidylate kinase activities and of the feedbach inhibition of thymidine kinase in normal and neoplastic human tissue”. Cancer Res. 28 (10): sid. 2068–77. PMID 5696936. http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=5696936.

Stafford MA, Jones OW (August 1972). ”The presence of "fetal" thymidine kinase in human tumors”. Biochim. Biophys. Acta 277 (2): sid. 439–42. PMID 4672678.

Maehara Y, Nakamura H, Nakane Y, et al. (April 1982). ”Activities of various enzymes of pyrimidine nucleotide and DNA syntheses in normal and neoplastic human tissues”. Gann 73 (2): sid. 289–98. PMID 6288502.

Persson L, Gronowitz SJ, Källander CF (1986). ”Thymidine kinase in extracts of human brain tumours”. Acta Neurochir (Wien) 80 (3–4): sid. 123–7. doi:10.1007/BF01812286. PMID 3012969.

Filanovskaia LI, Togo AV, Shcherbakova EG, Blinov MN (1994). ”[Thymidine kinase activity in leukocytes from patients with chronic myeloid leukemia at various periods in the disease]” (på russian). Vopr. Med. Khim. 40 (1): sid. 29–32. PMID 8122406.

Weber G, Lui MS, Takeda E, Denton JE (September 1980). ”Enzymology of human colon tumors”. Life Sci. 27 (9): sid. 793–9. doi:10.1016/0024-3205(80)90333-1. PMID 7412505.

Sagara T, Tsukada K, Iwama T, Mishima Y, Sakamoto S, Okamoto R (August 1985). ”[Thymidine kinase isozymes in human colon polyps]” (på japanese). Nippon Gan Chiryo Gakkai Shi 20 (7): sid. 1312–6. PMID 4078430.

Galloux H, Javre JL, Guerin D, Sampérez S, Jouan P (1988). ”[Prognostic value of fetal thymidine kinase measurements in breast cancer]” (på french). C. R. Acad. Sci. III, Sci. Vie 306 (3): sid. 89–92. PMID 3126994.

O'Neill KL, McKelvey VJ, Hoper M, et al. (December 1992). ”Breast tumour thymidine kinase levels and disease recurrence”. Med Lab Sci 49 (4): sid. 244–7. PMID 1339926.

Romain S, Javre JL, Samperez S, et al. (1990). ”[Prognostic value of thymidine kinase in cancer of the breast]” (på french). Bull Cancer 77 (10): sid. 973–83. PMID 2249017.

Yusa T, Tamiya N, Yamaguchi Y, et al. (March 1994). ”[A study of thymidine kinase activity in lung cancer tissue]” (på japanese). Nihon Kyobu Shikkan Gakkai Zasshi 32 (3): sid. 211–5. PMID 8189640.

Look KY, Moore DH, Sutton GP, Prajda N, Abonyi M, Weber G (1997). ”Increased thymidine kinase and thymidylate synthase activities in human epithelial ovarian carcinoma”. Anticancer Res. 17 (4A): sid. 2353–6. PMID 9252646.

Greengard O, Head JF, Chahinian AP, Goldberg SL (April 1987). ”Enzyme pathology of human mesotheliomas”. J. Natl. Cancer Inst. 78 (4): sid. 617–22. PMID 2882044.

Pikner R, Ludvíkova M, Ryska A, et al. (2005). ”TPS, thymidine kinase, VEGF and endostatin in cytosol of thyroid tissue samples”. Anticancer Res. 25 (3A): sid. 1517–21. PMID 16033053.

Wilmanns W, Wilms K (1972). ”DNA synthesis in normal and leucemic cells as related to therapy with cytotoxic drugs”. Enzyme 13 (1): sid. 90–109. PMID 4507104.

pubchem.ncbi.nlm.nih.gov

Tymidinkinas (Swedish Wikipedia)

aacrjournals.org

cancerres.aacrjournals.org

archive.is

asm.org

mcb.asm.org

jvi.asm.org

aac.asm.org

iai.asm.org

biomedcentral.com

doi.org

dx.doi.org

elsevier.com

linkinghub.elsevier.com

eurekaselect.com

harvard.edu

adsabs.harvard.edu

jbc.org

jst.go.jp

joi.jlc.jst.go.jp

nih.gov

ncbi.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

oxfordjournals.org

carcin.oxfordjournals.org

jnci.oxfordjournals.org

pnas.org

um.es

hh.um.es

web.archive.org

wikipedia.org

sv.wikipedia.org

wiley.com

onlinelibrary.wiley.com

worldcat.org